These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Benefits and risks of antifibrinolytic therapy in the management of ruptured intracranial aneurysms. A double-blind placebo-controlled study. Tsementzis SA; Hitchcock ER; Meyer CH Acta Neurochir (Wien); 1990; 102(1-2):1-10. PubMed ID: 2407050 [TBL] [Abstract][Full Text] [Related]
5. Myopathy due to epsilon amino-caproic acid. Kennard C; Swash M; Henson RA Muscle Nerve; 1980; 3(3):202-6. PubMed ID: 6990256 [TBL] [Abstract][Full Text] [Related]
6. [Anaphylactic shock in response to the administration of epsilon-aminocaproic acid]. Kazanbiev NK; Akhmedova DA; Gasanova RG; Bagamedov MM; Sfiev AA Klin Med (Mosk); 1987 Oct; 65(10):140-1. PubMed ID: 3431047 [No Abstract] [Full Text] [Related]
7. High does epsilon-aminocaproic acid prolongs the bleeding time and increases rebleeding and intraoperative hemorrhage in patients with subarachnoid hemorrhage. Glick R; Green D; Ts'ao C; Witt WA; Yu AT; Raimondi AJ Neurosurgery; 1981 Oct; 9(4):398-401. PubMed ID: 7301085 [TBL] [Abstract][Full Text] [Related]
8. Spontaneous thrombosis of an intracranial aneurysm during treatment with epsilon aminocaproic acid. Scott RM; Garrido E Surg Neurol; 1977 Jan; 7(1):21-3. PubMed ID: 831307 [TBL] [Abstract][Full Text] [Related]